Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Immune responses with and without previous SARS-CoV-2 infection following single BNT162b2 vaccine dose

Immune responses with and without previous SARS-CoV-2 infection following single BNT162b2 vaccine dose

Impact of mutations on binding affinity of SARS-CoV-2 variants with ACE2 and existing antibodies

Impact of mutations on binding affinity of SARS-CoV-2 variants with ACE2 and existing antibodies

Analysis of immunodeficient patients granted REGEN-COV under compassionate use COVID-19 program

Analysis of immunodeficient patients granted REGEN-COV under compassionate use COVID-19 program

Vaccinated patients hospitalized with COVID-19 in Norway spend fewer days in the hospital

Vaccinated patients hospitalized with COVID-19 in Norway spend fewer days in the hospital

Study shows 90.7% efficacy for the BNT162b2 COVID vaccine in 5-11 year-olds

Study shows 90.7% efficacy for the BNT162b2 COVID vaccine in 5-11 year-olds

RT-LAMP coupled solid-state nanopores for SARS-CoV-2 detection

RT-LAMP coupled solid-state nanopores for SARS-CoV-2 detection

Long-term effectiveness of Pfizer/BioNTech two-dose regimen mRNA vaccine

Long-term effectiveness of Pfizer/BioNTech two-dose regimen mRNA vaccine

Long-lasting anti-spike and anti-membrane antibodies can differentiate between COVID-19 infection and vaccination

Long-lasting anti-spike and anti-membrane antibodies can differentiate between COVID-19 infection and vaccination

New Delta sublineage shows no additional resistance to neutralization

New Delta sublineage shows no additional resistance to neutralization

Immunity following COVID-19 vaccination and natural infection in India

Immunity following COVID-19 vaccination and natural infection in India

Association between SARS-CoV-2 infections and areal level deprivation and ethnicity in England

Association between SARS-CoV-2 infections and areal level deprivation and ethnicity in England

COVID-19 trends identified from multiple linked EHR

COVID-19 trends identified from multiple linked EHR

Corrected method for more accurate estimation of SARS-CoV-2 reproduction number

Corrected method for more accurate estimation of SARS-CoV-2 reproduction number

Phage-like particle system provides a platform for quick and easy vaccine generation

Phage-like particle system provides a platform for quick and easy vaccine generation

Effectiveness of sotrovimab demonstrated in patients with mild to moderate COVID-19

Effectiveness of sotrovimab demonstrated in patients with mild to moderate COVID-19

Surveillance approaches to monitor the presence of SARS-CoV-2 in a fully vaccinated population

Surveillance approaches to monitor the presence of SARS-CoV-2 in a fully vaccinated population

Evidence that mild and even asymptomatic SARS-CoV-2 infection can lead to sustained immune activation

Evidence that mild and even asymptomatic SARS-CoV-2 infection can lead to sustained immune activation

First detection of SARS-CoV-2 remdesivir resistance in an immunocompromised patient

First detection of SARS-CoV-2 remdesivir resistance in an immunocompromised patient

Emergence of SARS-CoV-2 immune escape variants in an immunocompromised patient

Emergence of SARS-CoV-2 immune escape variants in an immunocompromised patient

Risk of severe COVID-19 is rare among fully vaccinated individuals in England

Risk of severe COVID-19 is rare among fully vaccinated individuals in England

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.